Abstract
A moderate reduction in coronary blood flow results in decreased myocardial oxygen consumption, accelerated glycolysis, decreased pyruvate oxidation, and lactate accumulation. To quantitatively understand cardiac metabolism during ischemia, we have developed a mechanistic, mathematical model based on biochemical mass balances and reaction kinetics in cardiac cells. By numerical solution of model equations, computer simulations showed the dynamic responses in glucose, fatty acid, glucose-6-phosphate, glycogen, triglyceride, pyruvate, lactate, acetyl-CoA, and free-CoA as well as CO2, O2 phosphocreatine/creatine, nicotinamide adenine dinucleotide (reduced form)/nicotinamide adenine dinucleotide (oxidized form) NADH/NAD+, and adenosine diphosphate/adenosine triphosphate (ADP/ATP). When myocardial ischemia was simulated by a 60% reduction in coronary blood flow, the model generated myocardial concentrations, uptakes, and fluxes that were consistent with experimental data from in vivopig studies. After 60 min of ischemia the concentrations of glycogen, phosphocreatine, and ATP were decreased by 60%, 75%, and 50%, respectively. With the onset of ischemia, myocardial lactate concentration increased and the myocardium switched from net consumer to net producer of lactate. Our model predicted a rapid 13-fold increase in NADH/NAD but only a twofold increase in the ratio of acetyl-CoA to free-CoA. These findings are consistent with the concept that pyruvate oxidation is inhibited during ischemia partially by the rise in NADH/NAD+. © 2002 Biomedical Engineering Society.
PAC2002: 8717Aa
Similar content being viewed by others
REFERENCES
Achs, M. J., and D. Garfinkel. Computer simulation of energy metabolism in anoxic perfused rat heart. Am. J. Physiol. 232:R164–R174, 1977.
Arai, A. E., G. A. Pantely, C. G. Anselone, J. Bristow, and J. D. Bristow. Active downregulation of myocardial energy requirements during prolonged moderate ischemia in swine. Circ. Res. 69:1458–1469, 1991.
Bell, G., T. Kayano, J. B. Buse, C. F. Burant, J. Takeda, D. Lin, H. Fukumoto, and S. Seino. Molecular biology of mammalian glucose transporters. Diabetes Care 13:198–208, 1990.
Cabrera, M. E., G. M. Saidel, and S. C. Kalhan. Lactate metabolism during exercise: Analysis by an integrative systems model. Am. J. Physiol. 277:R1522–R1536, 1999.
Cabrera, M. E., G. M. Saidel, and S. C. Kalhan. Role of O2 in regulation of lactate dynamics during hypoxia: Mathematical model and analysis. Ann. Biomed. Eng. 26:1–27, 1998.
Ch'en, F. F.–T., R. D. Vaughan–Jones, K. Clarke, and D. Noble. Modeling myocardial ischaemia and reperfusion. Prog. Biophys. Mol. Biol. 69:515–538, 1998.
Comte, B., G. Vincent, B. Bouchard, M. Jette, S. Cordeau, and C. Des Rosiers. A 13C mass isotopomer study of anaplerotic pyruvate carboxylation in perfused rat hearts. J. Biol. Chem. 272:26125–26131, 1997.
Gertz, E., J. Wisneski, R. Neese, J. Bristow, G. Searle, and J. Hanlon. Myocardial lactate metabolism: Evidence of lactate release during net chemical extraction in man. Circulation 63:1273–1279, 1981.
Gertz, E. W., J. A. Wisneski, W. C. Stanley, and R. A. Neese. Myocardial substrate utilization during exercise in humans. J. Clin. Invest. 82:2017–2025, 1988.
Hacker, T., J. Hall, C. Stone, and W. C. Stanley. Alanine, glutamate, and ammonia exchanges in acutely ischemic swine myocardium. Basic Res. Cardiol. 87:184–192, 1992.
Hall, J. L., G. D. Lopaschuk, A. Barr, J. Bringas, R. D. Pizzurro, and W. C. Stanley. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels. Cardiovasc. Res. 32:879–885, 1996.
Hall, J. L., W. C. Stanley, G. D. Lopaschuk, J. A. Wisneski, R. D. Pizzurro, C. D. Hamilton, and J. G. McCormack. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine–induced work. Am. J. Physiol. 271:H2320–H2329, 1996.
Hansford, R., and L. Cohen. Relative importance of pyruvate dehydrogenase interconversion and feed–back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria. Arch. Biochem. Biophys. 191:65–81, 1978.
Herman, R. H., R. M. Cohn, and P. D. McNamara. Principles of Metabolic Control in Mammalian Systems. New York: Plenum Press, 1980, p. 669.
Jafri, M. S., S. J. Dudycha, and B. O'Rourke. Cardiac energy metabolism: Models of cellular respiration. Annu. Rev. Biomed. Eng. 3:57–81, 2001.
James, D. E., M. Strube, and M. Mueckler. Molecular cloning and characterization of an insulin–regulatable glucose transporter. Nature (London) 338:83–87, 1989.
Joshi, A., and B. O. Palsson. Metabolic dynamics in the human red cell. Part I A comprehensive kinetic model; Part II Interactions with the environment. J. Theor. Biol. 141:515–528, 1989.
Joshi, A., and B. O. Palsson. Metabolic dynamics in the human red cell. Part III Metabolic reaction rates; Part IV Data prediction and some model computations. J. Theor. Biol. 142:41–85, 1990.
Kashiwaya, Y., K. Sato, N. Tsuchiya, S. Thomas, D. A. Fells, R. L. Veech, and J. V. Passonneau. Control of glucose utilization in working perfused rat heart. J. Biol. Chem. 269:25502–25514, 1994.
Katz, A., A. Edlund, and K. Sahlin. NADH content and lactate production in the perfused rabbit heart. Acta Physiol. Scand. 130:193–200, 1987.
Lasley, R. D., Z. Zhou, J. O. Hegge, R. Bunger, and R. M. Mentzer, Jr. Adenosine attenuates in vivo myocardial stunning with minimal effects on cardiac energetics. Basic Res. Cardiol. 93:303–312, 1998.
Liedtke, A. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog. Cardiovasc. Dis. 23:321–326, 1981.
Lopaschuk, G. D., D. D. Belke, J. Gamble, T. Itoi, and B. O. Schonekess. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim. Biophys. Acta 1213:263–276, 1994.
McNulty, P. H., A. J. Sinusas, C. Q.–X. Shi, D. Dione, L. H. Young, G. C. Cline, and G. I. Shulman. Glucose metabolism distal to a critical coronary stenosis in a canine model of low–flow myocardial ischemia. J. Clin. Invest. 98:62–69, 1996.
Neely, J., and L. Grotyohann. Role of glycolytic products in damage to ischemic myocardium. Circ. Res. 55:816–824, 1984.
Opie, L. H. The Heart: Physiology and Metabolism. New York: Raven, 1991.
Panchal, A. R., B. Compte, H. Huang, T. Kerwin, A. Darvish, C. Des Rosiers, H. Brunengraber, and W. C. Stanley. Partitioning of pyruvate between oxidation and anaplerosis in swine heart. Am. J. Physiol. 279:H2390–H2398, 2000.
Pantely, G. A., S. A. Malone, W. S. Rhen, C. G. Anselone, A. E. Arai, J. Bristow, and J. D. Bristow. Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ. Res. 67:1481–1493, 1990.
Stanley, W. C. Cardiac energetics during ischaemia and the rationale for metabolic interventions. Coron. Artery Dis. 12:S3–S7, 2001.
Stanley, W. C. In vivo models of myocardial metabolism during ischemia: Application to drug discovery and evaluation. J. Pharmacol. Toxicol. Methods 43:133–140, 2000.
Stanley, W. C., J. L. Hall, K. R. Smith, G. D. Cartee, T. A. Hacker, and J. A. Wisneski. Myocardial glucose transporters and glycolytic metabolism during ischemia in hyperglycemic diabetic swine. Metabolism 43:61–69, 1994.
Stanley, W. C., J. L. Hall, C. K. Stone, and T. A. Hacker. Acute myocardial ischemia causes a transmural gradient in glucose extraction but not glucose uptake. Am. J. Physiol. 262:H91–H96, 1992.
Stanley, W. C., L. A. Hernandez, D. Spires, J. Bringas, S. Wallace, and J. G. McCormack. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: Effects of dichloroacetate. J. Mol. Cell. Cardiol. 28:905–914, 1996.
Stanley, W. C., G. D. Lopaschuk, J. L. Hall, and J. G. Mc–Cormack. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions: Potential for pharmacological interventions. Cardiovasc. Res. 33:243–257, 1997.
Sumi, T., and M. Ui. Allosteric properties of enzymes with “ping–pong” mechanism. Biochim. Biophys. Acta 276:12–18, 1972.
Taegtmeyer, H. Energy metabolism of the heart: From basic concepts to clinical applications. Curr. Probl. Cardiol. 19:62–113, 1994.
van der Vusse, G., M. van Bilsen, and J. Glatz. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc. Res. 45:279–293, 2000.
Williamson, J. R., and B. E. Corkey. Assay of citric acid cycle intermediates and related compounds—Update with tissue metabolite levels and intracellular distribution. In: Biomembranes, Part F: Bioenergetics—Oxidative Phosphorylation, edited by S. Fleischer and L. Packer. New York: Academic, 1979, pp. 200–222.
Wisneski, J. A., E. W. Gertz, R. A. Neese, L. D. Gruenke, D. L. Morris, and J. C. Craig. Metabolic fate of extracted glucose in normal human myocardium. J. Clin. Invest. 76:1819–1827, 1985.
Wisneski, J. A., E. W. Gertz, R. A. Neese, and M. Mayr. Myocardial metabolism of free fatty acids: Studies with 14C–labeled substrates in humans. J. Clin. Invest. 79:359–366, 1987.
Wisneski, J. A., W. C. Stanley, R. A. Neese, and E. W. Gertz. Effects of acute hyperglycemia on myocardial glycolytic activity in humans. J. Clin. Invest. 85:1648–1656, 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salem, J.E., Saidel, G.M., Stanley, W.C. et al. Mechanistic Model of Myocardial Energy Metabolism Under Normal and Ischemic Conditions. Annals of Biomedical Engineering 30, 202–216 (2002). https://doi.org/10.1114/1.1454133
Issue Date:
DOI: https://doi.org/10.1114/1.1454133